OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa
SUWON, South Korea, May 10, 20…
The Art & Science of Wellness
SUWON, South Korea, May 10, 20…
–1Q19 Total Sales Up 15.…
-XI(TM) Smart Raman provides r…
World Lupus Federation global …
-‘Next generation’…
AUSTIN, Texas, May 7, 2019 /PR…
多語言WordPress ,採用WPML